Editorials

• Circulating ST2, from biomarker to pathogenic mediator

  Domingo Pascual-Figal, Antonio Lax, María Carmen Asensio López

  Rev Esp Cardiol. 2023;76:672-4

• Thrombus aspiration in AMI patients with cardiogenic shock: is thrombus burden the missing piece of the puzzle?

  Giampiero Vizzari, Giuseppe De Luca

  Rev Esp Cardiol. 2023;76:677-8

• Coronary computed tomography angiography in asymptomatic patients with diabetes

  Alberto Bouzas-Mosquera, David Viladés-Medel, Javier Muñiz

  Rev Esp Cardiol. 2023;76:675-6

• Syncope and bundle branch block: a single study with several take-home messages

  Nicasio Pérez-Castellano, David Calvo Cuervo, Julián Pérez-Villacastín

  Rev Esp Cardiol. 2023;76:582-4

• Subspecialties in Cardiology: areas of specific training

  Ángel Cequier, David Calvo, Belén Cid

  Rev Esp Cardiol. 2023;76:585-8

• How can we improve our outcomes in myocardial infarction? Use of IVUS in high-risk patients

  Enrique Gutiérrez Ibañes, Josep Gómez Lara

  Rev Esp Cardiol. 2023;76:580-1

• New challenges in the management of patients with transthyretin cardiac amyloidosis: beyond oral anticoagulation

  Fernando de Frutos, Esther Gonzalez-Lopez

  Rev Esp Cardiol. 2023;76:494-6

• Ten years of the RECALCAR registry: reflections on cardiovascular care in Spain

  Rafael Salguero-Bodes, Fernando Arribas-Ynsaurriaga

  Rev Esp Cardiol. 2023;76:500-2

• Chronotropic incompetence: rediscovering phenotypes in heart failure with preserved ejection fraction

  Santiago Jiménez-Marrero, Raúl Ramos, Josep Comín-Colet

  Rev Esp Cardiol. 2023;76:497-9

• Stand-alone surgery for atrial fibrillation

  Manuel Carnero-Alcázar, Luis Maroto-Castellanos, Juan José González-Ferrer

  Rev Esp Cardiol. 2023;76:398-401

• Comments on the 2022 ESC guidelines on cardio-oncology

  SEC Working Group for the 2022 ESC guidelines on cardio-oncology and SEC Guidelines Committee

  Rev Esp Cardiol. 2023;76:409-16

• Comments on the 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

  SEC Working Group for the 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death and SEC Guidelines Committee

  Rev Esp Cardiol. 2023;76:402-8

• Comments on the ESC 2022 guidelines on cardiovascular assessment and management of patients undergoing noncardiac surgery

  SEC Working Group on the 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing noncardiac surgery and SEC Guidelines Committee

  Rev Esp Cardiol. 2023;76:287-93

• Comments on the 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension

  SEC Working Group for the 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension and SEC Guidelines Committe

  Rev Esp Cardiol. 2023;76:294-300

• Cardiac filaminopathies: lights and shadows in the phenotype associated with the FLNC gene

  Tomás Ripoll-Vera

  Rev Esp Cardiol. 2023;76:284-6

• Insights on the first report of the Spanish registry of durable mechanical support (REGALAD)

  Sharan Malkani, José Nativi-Nicolau

  Rev Esp Cardiol. 2023;76:218-9

• Antiplatelet therapy after complex percutaneous coronary intervention and in left main coronary disease. Not all lesions are the same

  Juan M. Ruiz-Nodar

  Rev Esp Cardiol. 2023;76:223-6

• Should cardiac resynchronization therapy be prescribed before optimizing medical therapy in patients with left bundle branch block-induced cardiomyopathy?

  Jorge Toquero Ramos

  Rev Esp Cardiol. 2023;76:220-2

• Looking into the future of ACS patients through the small OCT window

  Alp Aytekin, Adnan Kastrati

  Rev Esp Cardiol. 2023;76:140-2

• Medina classification since its description in 2005

  Manuel Pan, Soledad Ojeda

  Rev Esp Cardiol. 2023;76:146-9